The elmiric acids: biologically active anandamide analogs.
elmiric Acids:具有生物活性的 anandamide 类似物。
基本信息
- 批准号:7894890
- 负责人:
- 金额:$ 32.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-08-01 至 2012-01-31
- 项目状态:已结题
- 来源:
- 关键词:2-arachidonylglycerolAbbreviationsAbsence of pain sensationAcidsAcuteAdverse effectsAirAmidohydrolasesAnabolismAnti-Inflammatory AgentsAnti-inflammatoryApplications GrantsBindingBiologicalBiological AssayBiological ModelsBrainCNR1 geneCalcium ionCannabinoidsCategoriesCell Culture TechniquesCell physiologyCellsChemical StructureChemicalsChinese Hamster Ovary CellChronicCommunitiesDataDependencyDrug usageEndocannabinoidsEnzyme-Linked Immunosorbent AssayEnzymesExposure toFamilyFamily memberFibroblastsFutureGene SilencingGlycineGoalsHydrolysisImmunoassayIn VitroInflammationInflammatoryInflammatory ResponseInhibition of Cell ProliferationInjuryInterleukin-6InterleukinsLigandsLinkLipopolysaccharidesLipoxygenaseLiquid substanceMass Spectrum AnalysisMeasuresMediatingMediator of activation proteinMedicalModelingMolecularMusN-arachidonylglycineNamesNarcoticsNomenclatureNon-Steroidal Anti-Inflammatory AgentsNuclearOrphanPainPeritoneal FluidPeritonitisPharmaceutical PreparationsPhysiologicalPlatelet Activating FactorProceduresProstaglandin-Endoperoxide SynthaseProstaglandinsRattusReportingResearch SupportRheumatoid ArthritisRiskRoleSamplingScintillation CountingStructure-Activity RelationshipSuggestionSynovial CellSystemTNF geneTRPV1 geneTestingTetrahydrocannabinolThioglycolatesTimeTissuesTumor Necrosis Factor-alphaTumor Necrosis FactorsWorkaddictionajulemic acidamidaseanaloganandamidebasecapsaicin receptorcytokinefallsfatty acid amide hydrolasefollow-upgamma-Aminobutyric Acidgamma-Linolenic Acidglycine transporterhuman GPRC5C proteinin vitro Modelin vivoinhibitor/antagonistinnovationinsightinterestmembermonocytenovelperipheral bloodprogesterone 11-hemisuccinate-(2-iodohistamine)receptorresearch studyresponsesubcutaneous
项目摘要
As chemical entities, lipoamino acids have been known for some time. However, more
recently their occurrence and importance in mammalian species has been discovered. They
appear to have close relationships with the endocannabinoids not only structurally but also
in terms of biological actions. The latter include analgesia, anti-inflammatory effects,
inhibition of cell proliferation and calcium ion mobilization. To date about 40 naturally
occurring members of this family have been identified and, additionally, several synthetic
analogs have been prepared and studied. To facilitate their identity, a nomenclature system
has been suggested based on the name elmiric acid (EMA). The prototypic example, N-arachidonoyl glycine does not bind to CBI, however it does inhibit the glycine transporter
GLYT2a and also appears to be a ligand for the orphan G-protein-coupled receptor GPRI8.
It may also have a role in regulating tissue levels of anandamide by virtue of its inhibitory
effect on FAAH the enzyme that mediates inactivation of anandamide. Its concentration in
rat brain is several times higher than anandamide supporting its possible role as a
physiological mediator. Future studies should be aimed at elucidating the actions of all of
the members of this interesting family of molecules and gaining further insight into possible
mechanisms of action. A promising use for these compounds would be as narcotic
replacement agents.
作为化学实体,脂氨基酸已经知道一段时间了。但更多
最近发现了它们在哺乳动物中的存在和重要性。他们
似乎与内源性大麻素不仅在结构上,
在生物行为方面。后者包括镇痛,抗炎作用,
抑制细胞增殖和钙离子动员。约40个自然约会
已经鉴定了该家族的发生成员,此外,还鉴定了几种合成的
已经制备和研究了类似物。为了便于识别,
已建议基于名称elmiric酸(EMA)。典型的例子是N-花生四烯酰甘氨酸不与CBI结合,但它确实抑制甘氨酸转运蛋白
GLYT 2a也似乎是孤儿G蛋白偶联受体GPRI 8的配体。
它也可能通过其抑制作用调节组织中大麻素的水平。
对FAAH的影响,FAAH是介导花生四烯酸失活的酶。中的浓度
大鼠大脑中的含量是花生四烯酸的数倍,这支持了它作为一种
生理介质未来的研究应旨在阐明所有的行动,
这个有趣的分子家族的成员,并进一步了解可能的
行动机制。这些化合物的一个有希望的用途是作为麻醉剂
替代代理人。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SUMNER HOWARD BURSTEIN其他文献
SUMNER HOWARD BURSTEIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SUMNER HOWARD BURSTEIN', 18)}}的其他基金
The elmiric acids: biologically active anandamide analogs.
elmiric Acids:具有生物活性的 anandamide 类似物。
- 批准号:
7727687 - 财政年份:2009
- 资助金额:
$ 32.43万 - 项目类别:
Endocannabinoid Analogs as Anti-inflammatory Agents
作为抗炎剂的内源性大麻素类似物
- 批准号:
7106374 - 财政年份:2004
- 资助金额:
$ 32.43万 - 项目类别:
Endocannabinoid Analogs as Anti-inflammatory Agents
作为抗炎剂的内源性大麻素类似物
- 批准号:
6951593 - 财政年份:2004
- 资助金额:
$ 32.43万 - 项目类别:
Endocannabinoid Analogs as Anti-inflammatory Agents
作为抗炎剂的内源性大麻素类似物
- 批准号:
6749403 - 财政年份:2004
- 资助金额:
$ 32.43万 - 项目类别:
Endocannabinoid Analogs as Anti-inflammatory Agents
作为抗炎剂的内源性大麻素类似物
- 批准号:
7678732 - 财政年份:2004
- 资助金额:
$ 32.43万 - 项目类别:
NON PSYCHOACTIVE CANNABINOIDS WITH THERAPEUTIC POTENTIAL
具有治疗潜力的非精神活性大麻素
- 批准号:
6175550 - 财政年份:1999
- 资助金额:
$ 32.43万 - 项目类别:
NON PSYCHOACTIVE CANNABINOIDS WITH THERAPEUTIC POTENTIAL
具有治疗潜力的非精神活性大麻素
- 批准号:
2902241 - 财政年份:1999
- 资助金额:
$ 32.43万 - 项目类别:
NON PSYCHOACTIVE CANNABINOIDS WITH THERAPEUTIC POTENTIAL
具有治疗潜力的非精神活性大麻素
- 批准号:
6378830 - 财政年份:1999
- 资助金额:
$ 32.43万 - 项目类别:
NON PSYCHOACTIVE CANNABINOIDS WITH THERAPEUTIC POTENTIAL
具有治疗潜力的非精神活性大麻素
- 批准号:
6515659 - 财政年份:1999
- 资助金额:
$ 32.43万 - 项目类别:
BIOSYNTHESIS OF ANANDAMIDE--A NOVEL EICOSANOID
新型二十烷酸阿南达胺的生物合成
- 批准号:
2122673 - 财政年份:1995
- 资助金额:
$ 32.43万 - 项目类别:
相似海外基金
Real-time Disambiguation of Abbreviations in Clinical Notes
临床记录中缩写词的实时消歧
- 批准号:
8077875 - 财政年份:2010
- 资助金额:
$ 32.43万 - 项目类别:
Real-time Disambiguation of Abbreviations in Clinical Notes
临床记录中缩写词的实时消歧
- 批准号:
7866149 - 财政年份:2010
- 资助金额:
$ 32.43万 - 项目类别:
Real-time Disambiguation of Abbreviations in Clinical Notes
临床记录中缩写词的实时消歧
- 批准号:
8589822 - 财政年份:2010
- 资助金额:
$ 32.43万 - 项目类别:
Real-time Disambiguation of Abbreviations in Clinical Notes
临床记录中缩写词的实时消歧
- 批准号:
8305149 - 财政年份:2010
- 资助金额:
$ 32.43万 - 项目类别:














{{item.name}}会员




